MiR-4689 has been reported to effectively inhibit Kirsten rat sarcoma virus (KRAS)-driven epidermal growth factor receptor (EGFR) signaling by directly inhibiting KRAS and AKT1 in colorectal cancer cells [14]. Here, KRAS is linked to colorectal cancer.